Show simple item record

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion

dc.contributor.authorFarhat, Ryan M.
dc.contributor.authorMousa, Mohammad A.
dc.contributor.authorDaas, Eshaan J.
dc.contributor.authorGlassberg, Marilyn K.
dc.date.accessioned2021-04-02T20:02:05Z
dc.date.available2021-04-02T20:02:05Z
dc.date.issued2020-07
dc.identifier.citationFarhat, R. M., Mousa, M. A., Daas, E. J., & Glassberg, M. K. (2020). Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion. Frontiers in Medicine, 7.
dc.identifier.issn2296-858X
dc.identifier.pmid32850916
dc.identifier.doi10.3389/fmed.2020.00435
dc.identifier.urihttp://hdl.handle.net/10150/657414
dc.description.abstractThe novel coronavirus (COVID-19) has continued its global spread since the first documented case in late 2019 in Wuhan, China. With over 10 million cases and 500 thousand deaths reported worldwide, the need for an effective treatment regimen is evident. Historically, convalescent plasma (CP) has been utilized in the treatment of viral respiratory pathogens. Critically ill patients with COVID-19 in China and South Korea have been treated with CP given the ineffectiveness of experimental therapies with antivirals alone. This commentary explores the importance of published experience and the pending establishment of efficacy to facilitate an informed decision regarding the therapeutic use of CP. With increasing mortality around the world from COVID-19 infection, the need for alternative, effective treatment regimens is critical.
dc.language.isoen
dc.publisherFRONTIERS MEDIA SA
dc.rightsCopyright © 2020 Farhat, Mousa, Daas and Glassberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectcoronavirus (2019-nCoV)
dc.subjectSARS-CoV-2
dc.subjecttransfusion safety
dc.subjectneutralizing antibody titers (NAT)
dc.subjectconvalescent plasma for COVID-19 therapy
dc.titleTreatment of COVID-19: Perspective on Convalescent Plasma Transfusion
dc.typeArticle
dc.typetext
dc.identifier.eissn2296-858X
dc.contributor.departmentUniv Arizona, Coll Med Phoenix
dc.contributor.departmentUniv Arizona, Coll Med Phoenix, Dept Med, Div Pulm Crit Care & Sleep Med
dc.identifier.journalFRONTIERS IN MEDICINE
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitleFRONTIERS IN MEDICINE
refterms.dateFOA2021-04-02T20:02:05Z


Files in this item

Thumbnail
Name:
fmed-07-00435.pdf
Size:
144.4Kb
Format:
PDF
Description:
Final Published Version
Download

This item appears in the following Collection(s)

Show simple item record

Copyright © 2020 Farhat, Mousa, Daas and Glassberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Except where otherwise noted, this item's license is described as Copyright © 2020 Farhat, Mousa, Daas and Glassberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).